To investigate the relationship between 27 bp repeat polymorphism in intron 4 in the endothelial nitric oxide synthase (eNOS4) gene and essential hypertension in the Kazakh Chinese population, 151 patients with essential hypertension and 138 healthy people were selected from the Boertonggu countryside of Shawan region in the Xinjiang Uygur Autonomous Region of China in 2006. The polymorphism of eNOS in the two groups was detected with polymerase chain reaction assays and the genotype frequencies in each group were calculated following the Hardy-Weinberg law. Four and five tandem 27 bp repeats were designated as "a" and "b", respectively. It was found that the frequencies of b/b, b/a and a/a genotypes of the eNOS4 gene were 84.06%, 15.22% and 0.72% in the control group, and 81.46%, 15.89% and 2.65% in the hypertension group, respectively. The frequencies of gene "b" and "a" were 91.67% and 8.33% in the control group and 89.40% and 10.60% in the hypertension group, respectively. It was found that plasma eNOS activity was not associated with genotypes and alleles of eNOS gene. Plasma eNOS activity in the hypertension group was significantly decreased compared with the control group (P<0.01). The results suggest that eNOS4 gene polymorphisms are unlikely to be the major genetic susceptibility factors for essential hypertension in the Xinjiang Kazakh population. However, a positive association between plasma eNOS activity and essential hypertension has been revealed.
Hypertension is a multifactorial disease with genetic and environmental components. As nitric oxide (NO) is a major regulator in the cardiovascular system [1] , it is hypothesized that abnormality in the activity of endothelial nitric oxide synthase (eNOS) might lead to NO deficiency and cause clinical hypertension [2] . The eNOS gene was mapped on chromosome 7q36 [3] . It consists of 26 exons spanning approximately 21 kb of genomic DNA and encoding an mRNA of 4052 nucleotides. A 27 bp repeat in intron 4 of eNOS (eNOS4) was found to be important in the occurrence and severity of essential hypertension, but the results of most associated studies were inconsistent among different ethnic groups. Wang et al. [4] reported that eNOS4 genotype polymorphism is related to the activity of eNOS in European populations. Pulkkinen et al. [5] reported that the 4a allele of the eNOS gene was associated with elevated diastolic (P=0.032) and mean arterial blood pressure (P=0.030) in the Japanese population, whereas Yokoyama et al. [6] found no association between "a" allele gene polymorphism and essential hypertension in Japanese.
eNOS4 gene belongs to nonfunctional variable that does not change the structure of protein product at all; the "a" allele is just a marker which does not take part in hypertension genesis directly. However, some investigators reported that the "a" allele could be a risk factor for essen-tial hypertension [7] . Tsukada et al. [8] presumed that the polymorphisms of eNOS gene affect the splicing of mRNA. So we hypothesize that the "a" allele links disequilibrium and real gene locus associated with hypertension genesis. In order to test this hypothesis, we designed and carried out this study. The incidence of hypertension in the Kazakh Chinese population is 17.36% [9] . Kazakh Chinese localize in relatively isolated places where transport is inconvenient. There was no miscegenation among the Kazakh Chinese who took part in this study.
The specific aim of this study was to investigate the association of the polymorphisms of eNOS and its activity with essential hypertension in a relatively large sample of Kazakh Chinese. In addition, we tried to reveal the possible relation between plasma eNOS activity and individual polymorphism in different subjects.
Materials and Methods

Participants and data collection
Kazakh Chinese without miscegenation were selected from the Boertonggu countryside of Shawan region in the Xinjiang Uygur Autonomous Region of China in 2006. All subjects were herders and agreed to take part in the study. Participants' eligibility was confirmed by questionnaire and clinical examinations after enrolment in the study. Our research group comprised of approximately 30 professionals in epidemiology, pathophysiology and hereditism, and clinical/occupational specialists. We travelled to the Boertonggu countryside six times and the local government provided us with details of 800 Kazakhs aged from 20 to 73 years. From the 310 essential hypertensive and 490 healthy subjects in this group we chose 151 essential hypertensive and 138 healthy Kazakhs by random cluster sampling. The comprehensive investigation questionnaire, essential auxiliary examination and clinical diagnosis were completed for each individual. We used the comparison design and analysis. The results showed that there was no age or sex statistical difference between those with or without essential hypertension. The minimal sample size was 127 cases for the eNOS4 gene in each group, which was calculated using A total of 289 participants were enrolled in this study. They included 59 male and 92 female Kazakh Chinese with essential hypertension, aged 20 to 73 years, and 54 male and 84 female healthy Kazakh Chinese, aged 20 to 73 years, who did not have physician-diagnosed hypertension, diabetes, coronary heart disease, stroke, any other lifethreatening diseases or any history of drug abuse. The 1999 WHO/ISH Hypertension Guidelines were used to diagnose essential hypertension as systolic pressure=140 mmHg (18.7 kPa) and/or diastolic pressure=90 mmHg (12.0 kPa). Participants' blood pressure was measured after 15 min of rest and repeated three times. A nurse recorded participants' height, weight, waist-to-hip ratio, and blood pressure measurements, and doctors conducted participants' electrocardiographic examination and abdominal ultrasound examination. Overnight fasting blood (15 ml) was drawn and processed (centrifuged, separated, frozen and packaged in a −80 ºC freezer) for plasma eNOS activity quantification. Blood cells were prepared for DNA extraction and detection of gene polymorphism.
Genotype assay of eNOS4
Genomic DNA was extracted from 0.2 ml of whole blood sample using an SK1252 DNA extraction kit (Sangon, Shanghai, China). Genotyping of each polymorphism was carried out by polymerase chain reaction amplification from 30 to 50 ng of genomic DNA. For eNOS4 genotyping, the polymerase chain reaction primers were designed to flank the 27 bp direct repeat. The primer sequences were 5'-AGGCCCTATGGTAGTGCCTT-3' (forward) and 5'-TCTCTTAGTGCTGTGGTCAC-3' (reverse). Each assay was conducted in a 25 μl mixture containing 1.2 U Taq DNA polymerase (BBI, Markham, Canada), 0.5 μM appropriate primer and 250 μM dNTP. Each reaction was initially denatured for 5 min at 94 ºC, followed by 35 cycles of 94 ºC for 60 s, 60.2 ºC for 60 s, and 72 ºC for 60 s, with a final extension at 72 ºC for 10 min. The smaller allele has four tandem 27 bp repeats and was designated as "a"; the larger allele that has five tandem 27 bp repeats was designated as "b". The eNOS alleles "a" and "b" were identified as fragments corresponding to 393 bp and 420 bp respectively, after separation on 3% agarose gel (BBI) stained with ethidium bromide (Fig. 1) . In addition, the 27 bp repeat elements were verified by DNA sequencing (Shanghai GeneCore BioTechnologies, Shanghai, China).
Quantitation of plasma nitric oxide synthase activity
Quantitation of plasma eNOS activity was determined colorimetrically using an assay kit from Nanjing Jiancheng (Nanjing, China). Absorbance at 530 nm was measured using a Model 680 Microplate Spectrophotometer (BioRad, Hercules, USA). The activity of eNOS (unit per http://www.abbs.info; www.blackwellpublishing.com/abbs milliliter) was calculated following the manufacturer's instructions.
Statistical analysis
Continuous variables were presented as mean±SD and differences between two groups were tested using Student's t-test and differences of discrete variables were tested using the χ 2 -test. The Hardy-Weinberg equilibrium of polymorphism was assessed by the χ 2 -test. Differences were considered statistically significant at P<0.05.
Results
Clinical characteristics of participants
The clinical characteristics of the 151 hypertensive and 138 normotensive subjects are summarized in Table 1 . In addition to higher body mass index, systolic blood pressure and diastolic blood pressure, (P<0.01), the hypertensive subjects also had a higher plasma total cholesterol level than the controls (P<0.05). There was no significant difference between the hypertensive and control groups for smoking status. No differences between the two groups were noted with respect to age, gender, triglyceride, lowdensity lipoprotein cholesterol or high-density lipoprotein cholesterol (P>0.05).
Distribution of selected eNOS polymorphisms
The distribution of eNOS4 polymorphisms in the 289 Chinese Kazakhs did not deviate from the Hardy-Weinberg equilibrium. The genotype and allele frequencies were not significantly different between the two groups (P>0.05) ( Table 2) . eNOS4 genotypes and hypertension multiple logistic regression analysis are summarized in Table 3 . Body mass index, plasma total cholesterol and high-density lipoprotein cholesterol were significantly higher in the hypertensive group than in the control group (P<0.05). No differences between the two groups were noted with respect to eNOS genotypes, gender, age, triglyceride, low-density lipoprotein cholesterol or smokers (P>0.05).
Association of eNOS4 genotype and allele with plasma eNOS activity
Mean values of plasma eNOS activity were not significantly different by genotype or allele. Overall, there was statistically significant difference between control and essential hypertension groups (P<0.001) ( Table 4) .
Discussion
Kazakhs represent the major minority ethnic group in Genomic DNA extracted from whole blood sample was used as a PCR template and PCR products were separated on 3% agarose gel stained with ethidium bromide. The smaller allele with four tandem 27 bp was designated as ''a'' (393 bp) and the larger allele with five tandem 27 bp repeats was designated as ''b'' (420 bp). There were no significant differences in frequencies of genotypes and alleles between hypertensive and control groups (P>0.05). CI, confidence interval; OR, odds ratio. -, not applicable. Table 2 Frequency distribution of eNOS4 genotypes and alleles in Kazakh Chinese healthy and essential hypertension subjects Table 3 Multiple logistic regression analysis of Kazakh Chinese healthy and essential hypertension subjects eNOS4 genotypes and hypertension multiple logistic regression analysis are summarized. Body mass index (BMI), plasma total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) were significantly higher in the hypertensive group than the control group (P<0.05). No differences between the two groups were noted with respect to eNOS genotypes, gender, age, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) or smokers (P>0.05). B, regression coefficent; CI, confidence interval; OR, odds ratio; SE, standard error; Wald, χ 2 . -, not applicable.
http://www.abbs.info; www.blackwellpublishing.com/abbs
Xinjiang Uygur Autonomous Region, and the prevalence of essential hypertension in this population is the highest among all ethnic groups in the region. Kazakhs show a clear nation aggregation. Kazakhs generally live in isolated mountain areas where transportation is inconvenient. They do not have miscegenation. Moreover, they have more salt and fat and fewer vegetables in their diet. These factors contribute to the major environmental factor of essential hypertension in Kazakh populations in the Xinjiang Uygur Autonomous Region. Therefore, the Kazakh Chinese are ideal for essential hypertension research. Our study was to investigate the association of the polymorphisms of eNOS and its activity in essential hypertension of Kazakh Chinese. The genotype distributions and allele frequencies of eNOS polymorphisms in this study were similar to a previous report on Japanese [10] and Han Chinese [11] , but the "a" allele frequency of our study was significantly lower than that published for Caucasians (8.3% versus 15.0%) [12] . These results suggest that there are differences between different ethnic people and the polymorphism of the eNOS4 gene. Distribution of all polymorphisms is under the Hardy-Weinberg equilibrium, which suggests the results of this study are unlikely to be biased by population stratification or admixture for essential hypertension.
In our study of normotensive and essential hypertensive Chinese Kazakhs, there is no relationship between the selected eNOS4 polymorphisms and essential hypertension. The data of Yasujima et al. and Miyamota et al. [13, 14] showed 27 bp VNTR (variable number of tandem repeat) polymorphisms of Japanese were not associated with the genesis of essential hypertension. Some investigators have studied three clinically relevant polymorphisms (T786C, intron4b/a and G894T) of the eNOS gene with essential hypertension. Their results show that the three eNOS gene polymorphisms are unlikely to be major genetic susceptibility factors. Our results suggest that eNOS4 gene polymorphisms are unlikely to be the major genetic susceptibility factors for essential hypertension in the Xinjiang Kazakh population. However, our study showed that hypertension is related to plasma eNOS activity. The plasma eNOS activity of the hypertensive group was lower than that of the control group (P<0.001), and mean values of plasma eNOS activity were not significantly different by genotype or allele. So there was no relationship between eNOS activity and the eNOS4 polymorphisms in our study. A previous study by Zhao et al. [15] of 207 Han Chinese also indicated that plasma eNOS activity in those with essential hypertension was lower than that of the control group. However, their results indicated that the variations of eNOS4 might be responsible for the decreased activity of eNOS in hypertensive patients, because there was a lower level in individuals with the "a" allele. These conclusions further suggest that there was a difference between different ethnic people and the polymorphism of the eNOS4 gene. There is no more information available from literatures up to now. The possible reasons for the decreased eNOS activity in Kazakh Chinese hypertensive patients might be: (1) an eNOS cofactor (such as folacin) might be decreased in Kazakh Chinese hypertensive patients. Kazakh Chinese have few vegetables in their diet, which results in less folacin uptake; (2) the sequence variation of the regulatory eNOS gene might decrease its transcription; (3) the polymorphisms of eNOS affect the splicing of mRNA, in that changes at the protein level can also influence its activity; (4) the functional impairment of endothelial cells might be a significant factor for the high occurrence of essential hypertension. The results shown in Table 1 and Table 3 show that Kazakh hypertensive subjects had a higher plasma total cholesterol level than the control (P<0.05).
Higher cholesterol might lead to endothelium functional impairment [16] ; or (5) Xu et al. [17] reported that eNOS G894T genotype frequency is higher in male Kazakh Chinese (P=0.019). The relationship between other important polymorphisms, including the promoter polymorphism, tag SNPs (single nucleotide polyporphism), plasma eNOS activity, and the prevalence of essential hypertension should be examined. In our study, where was only a 0.72% frequency of the a/a genotype in the control group and a 2.65% frequency in the hypertension group, which might explain why there was no difference between these two groups regarding plasma eNOS activity for the a/a genotype. Kazakh Chinese represent a minority ethnic group in the Xinjiang district of China. Tremendous effort was made to recruit so many subjects in the present study, which is essential for revealing any potential association between eNOS4 polymorphism and hypertension. However, our study does not exclude any possible differences in eNOS4 polymorphism among specific nations. Whether the polymorphism is a causative variant or a marker of another functional variant in different races is still not clarified [18] . Further investigation is critically needed to determine the interaction among different situ of the eNOS4 gene, and interaction with other genes affecting the susceptibility of the Kazakh Chinese population to essential hypertension.
